Added to YB: 2026-08-20
Pitch date: 2026-08-18
COLO-B.CO [neutral]
Coloplast A/S
+9.26%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.
Market Cap
DKK 104.1B
Pitch Price
DKK 428.80
Price Target
N/A
Dividend
4.97%
EV/EBITDA
10.67
P/E
37.72
EV/Sales
4.47
Sector
Health Care Equipment and Supplies
Category
turnaround
Coloplast (COLOB Denmark): Continence Care strength
COLO-B.CO (update): Q3 rev +5.7% to DKK7.36bn (organic +6%), EBIT flat DKK1.91bn, 26% margin. Continence Care strongest (+8% on Luja); Ostomy soft (+5%) on China weakness. Kerecis -6% on reimbursement issues. FY26 guide maintained: 5-6% organic growth. Stabilizing but no clear acceleration.
Read full article (2 min)